Health & Biotech
Singular Health is a Western Australian, ASX-listed (ASX: SHG) medical technology company on a mission to create a seamless and integrated healthcare ecosystem where the full value of medical imaging records is unlocked, enabling universal access and promoting interoperability to maximise patient outcomes.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Emyria to create wearable device for psychedelics, while Telix gets FDA nod
Health & Biotech
Singular Health officially enters the Mediverse
Health & Biotech
ASX Health Stocks: Arovella and Imugene break away from the pack on major announcements
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ASX Health Stocks: Imugene joins forces with Merck and Pfizer for Phase 2 trial on gastric cancer
Health & Biotech
Singular Health Group forms 50/50 JV to commercialise VR software for mine optimisation
Tech
ASX Tech Stocks: Singular Health branches out with GeoVR Joint Venture for mining industry
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
Singular Health secures funding from CSIRO to develop AI-based cranial implants with Osteopore
News
ASX Small Cap Lunch Wrap: Who’s putting lipstick on a cloth this morning?
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
IPO Watch
IPO Watch: Which sector has provided the best performing IPOs in 2021?
News
Last Orders: Energy and health stocks send the ASX retreating again
News
Market highlights and 5 ASX small caps to watch on Thursday
News
Lunch Wrap: Who’s wooing who today?
News